Table 1.
Antimicrobials | VMP | HMP | Total MP | % over 374 MP | Dogs | % over 300 dogs |
---|---|---|---|---|---|---|
Beta-lactams | 146 | 55 | 201 | 53.7 | 187 | 62.3 |
Amoxicillin-clavulanic acid | 61 | 42 | 103 | 27.5 | 91 | 30.3 |
Amoxicillin/ampicillin | 43 | 1 | 44 | 11.8 | 44 | 14.7 |
Benzylpenicillin** | 2 | 2 | 0.5 | 2 | 0.7 | |
Cefalexin | 29 | 12 | 41 | 11.0 | 39 | 13.0 |
Cefovecin | 10 | 10 | 2.7 | 10 | 3.3 | |
Cefquinome | 1 | 1 | 0.3 | 1 | 0.3 | |
Fluoroquinolones | 41 | 5 | 46 | 12.3 | 44 | 14.7 |
Marbofloxacin | 23 | 23 | 6.1 | 23 | 7.7 | |
Enrofloxacin | 18 | 1 | 19 | 5.1 | 17 | 5.7 |
Ciprofloxacin | 4 | 4 | 1.1 | 4 | 1.3 | |
Aminoglycosides | 8 | 33 | 41 | 11.0 | 41 | 13.7 |
Neomycin | 6 | 13 | 19 | 5.1 | 19 | 6.3 |
Tobramycin | 12 | 12 | 3.2 | 12 | 4.0 | |
Gentamicin | 5 | 5 | 1.3 | 5 | 1.7 | |
Dihydrostreptomycin | 2 | 3 | 5 | 1.3 | 5 | 1.7 |
Imidazole derivatives | 8 | 28 | 36 | 9.6 | 36 | 12.0 |
Metronidazole | 8 | 28 | 36 | 9.6 | 36 | 12.0 |
Polymyxins | 12 | 3 | 15 | 4.0 | 15 | 5.0 |
Polymyxin B | 12 | 3 | 15 | 4.0 | 15 | 5.0 |
Tetracyclines | 8 | 6 | 14 | 3.7 | 14 | 4.7 |
Doxycycline | 8 | 6 | 14 | 3.7 | 14 | 4.7 |
Macrolides and lincosamides | 7 | 8 | 15 | 4.0 | 15 | 5.0 |
Spiramycin*** | 6 | 3 | 9 | 2.4 | 9 | 3.0 |
Clindamycin | 3 | 3 | 0.8 | 3 | 1.0 | |
Azithromycin | 2 | 2 | 0.5 | 2 | 0.7 | |
Tylosin | 1 | 1 | 0.3 | 1 | 0.3 | |
Sulphonamides | 3 | 8 | 11 | 2.9 | 11 | 3.7 |
Sulfadoxine -trimethoprim | 3 | 5 | 8 | 2.1 | 8 | 2.7 |
Formosulfathiazol | 3 | 3 | 0.8 | 3 | 1.0 | |
Others | 10 | 2 | 12 | 3.2 | 12 | 4.0 |
Florfenicol | 6 | 6 | 1.6 | 6 | 2.0 | |
Fusidic acid | 4 | 4 | 1.1 | 4 | 1.3 | |
Mupirocin | 2 | 2 | 0.5 | 2 | 0.7 |
Combinations: Metronidazole-spiramycin; sulfadoxine-trimethoprim; Benzylpenicillin-dihydrostreptomycin; polymyxin B-neomycin; formosulfathiazol-dihydrostreptomycin-neomycin;
Always in combination with streptomycin;
Always in combination with metronidazole.